Welcome to Investors.fagron.com - Homepage

investors.fagron.com

Description: Investors Fagron. Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 3 July 2017...

Google PR 0

Trustworthiness Good
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Good

Homepage - Fagron Investors

Investors.fagron.com: get to the top rated Investors Fagron pages and content popular with Brazil-based Investors.fagron.com users or check the following digest to find out more. Investors.fagron.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Investors Fagron team are just starting to conquer the social media and they have already achieved a promising result — 2 user activities so far (Google+ dominates with around 94% of all user reactions). Investors.fagron.com is hosted with A100 ROW GmbH in United States. Investors Fagron traffic is not yet estimated by Alexa.

Visit investors.fagron.com

Domain info

Location:	United States
Registrant:	Not Disclosed
Hosted by:	A100 ROW GmbH
Registrar:	Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Subnetworks:	18.199.36.219, 52.59.16.166

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: 2
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Investors.fagron.com popular pages to visit

Trading update eerste kwartaal 2017 | Fagron investor Relations Regulated information Nazareth (Belgium) / Rotterdam (The Netherlands), 3 July 2017 Fagron announces that the bond loan of € 225 million will be redeemed in full today. The bond...

Annual Reports - Fagron Fagron focuses on optimizing and innovating pharmaceutical compounding to widen the therapeutic scope of prescribers worldwide.

Press releases - Fagron Investors Key word(s) Fagron: Capital increase with preferential subscription rights of maximum € 88,265,360.40 through issuance of maximum 17,105,690 new shares at an issue price of € 5....